Methotrexate stimulates lung fibroblasts and epithelial cells to release eosinophil chemotactic activity

Journal of Rheumatology

Volumn 28, Issue 3, 2001, Pages 502-508

  Sato, E ^a   Camhi, S L ^a   Koyama, S ^a   Robbins, R A ^a  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

Chemotaxis; Drug induced pneumonitis; Eotaxin; Granulocyte macrophage colony stimulating factor; LTB4; Rantes

Indexed keywords

ACETIC ACID ETHYL ESTER; EOSINOPHIL CHEMOTACTIC FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE; TRYPSIN;

ARTICLE; CELL CULTURE; CELL STIMULATION; CELL TYPE; CHEMOTAXIS; CONTROLLED STUDY; EOSINOPHIL; EPITHELIUM CELL; HEAT; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SUPERNATANT;

ANTIBODIES; ANTIRHEUMATIC AGENTS; CELL LINE, TRANSFORMED; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; EPITHELIAL CELLS; FETUS; FIBROBLASTS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-5; LEUKOTRIENE B4; LUNG; METHOTREXATE; PHENYLPROPIONATES; PNEUMONIA; RANTES; RECEPTORS, LEUKOTRIENE B4;

EID: 0035097332     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Efficacy of low-dose methotrexate in rheumatoid arthritis
2. Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study
3. Methotrexate revisited: Effects of long-term treatment in psoriasis
4. Drug-induced pulmonary disease. Part 1: Cytoloxic drugs
5. Methotrexate pneumonitis. Bronchoalveolar lavage findings suggest an immunologic disorder
6. Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis
7. Methotrexate pneumonitis in rheumatoid arthritis: Potential risk factors. Four case reports and a review of the literature
8. Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis
9. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: Report of five cases and review of published reports
10. Methotrexate-induced pneumonitis
11. Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis
12. Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate
13. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis
14. Methotrexate therapy and pulmonary disease
15. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils
16. Rapid quanitification of neutrophil chemotaxis: Use of polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly
17. GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor
18. ONO-4057, a novel, orally active leukotriene B4 antagonist: Effects on LTB4-induced neutrophil functions
19. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents
20. Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract
21. Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis
22. Pathogenesis of "fibrosis" in interstitial pneumonia: An electron microscopic study
23. Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: Acute, chronic and drug-induced eosinophilic pneumonia
24. The eosinophil and the lung
25. Expression of eotaxin by human lung epithelial cells: Induction by cytokines and inhibition by glucocorticoids
26. Eosinophil peroxidase stimulates the release of granulocyte-macrophage colony-stimulating factor from bronchial epithelial cells
27. Human lung fibroblasts release chemokinetic activity for monocytes constitutively
28. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts
29. Interleukin-5 production by human airway epithelial cells
30. Low dose methotrexate pneumonitis in rheumatoid arthritis
31. Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: A case report and review of the literature
32. A study of the distribution of methotrexate in human tissues and tumors
33. Effects of leukotrienes B4 (LTB4) and D4 (LTD4) on motility of isolated normodense human eosinophils and neutrophils
34. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines
35. Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts
36. Eosinophils in the 1990s: New perspectives on their rule in health and disease
37. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate
38. Human granulocyte- and granulocyte-macrophage-colony stimulating factors are chemotactic and "competence" growth factors for human mesenchymal cells
39. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin
40. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions
41. Eosinophilic inflammation in asthma
42. Effect of low dose methotrexate on neutrophil chemotaxis induced by leukotriene B4 and complement C5a
43. Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients
44. Methotrexate inhibits polymorphonuclear leucocyte chemotaxis in psoriasis
45. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes
46. The effects of methotrexate on the production and activity of interleukin-1
47. Inhibition of basophil histamine release by methotrexate
48. The interleukins
49. Methotrexate pneumonitis in bronchial asthma